Solventum Corporation
SOLV
$85.26
-$0.01-0.01%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.40B | 8.39B | 8.31B | 8.25B | 8.22B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.40B | 8.39B | 8.31B | 8.25B | 8.22B |
| Cost of Revenue | 3.83B | 3.79B | 3.74B | 3.64B | 3.58B |
| Gross Profit | 4.57B | 4.60B | 4.56B | 4.61B | 4.63B |
| SG&A Expenses | 3.09B | 3.00B | 2.93B | 2.75B | 2.57B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.67B | 7.55B | 7.44B | 7.16B | 6.92B |
| Operating Income | 734.00M | 841.00M | 870.00M | 1.09B | 1.30B |
| Income Before Tax | 1.67B | 322.00M | 315.00M | 606.00M | 983.00M |
| Income Tax Expenses | 145.00M | -58.00M | -64.00M | 127.00M | 263.00M |
| Earnings from Continuing Operations | 1.52K | 380.00 | 379.00 | 479.00 | 720.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.52B | 380.00M | 379.00M | 479.00M | 720.00M |
| EBIT | 734.00M | 841.00M | 870.00M | 1.09B | 1.30B |
| EBITDA | 1.26B | 1.38B | 1.42B | 1.65B | 1.84B |
| EPS Basic | 8.75 | 2.19 | 2.19 | 2.77 | 4.16 |
| Normalized Basic EPS | 1.16 | 1.48 | 1.42 | 2.41 | 3.55 |
| EPS Diluted | 8.69 | 2.17 | 2.17 | 2.76 | 4.15 |
| Normalized Diluted EPS | 1.15 | 1.47 | 1.42 | 2.41 | 3.55 |
| Average Basic Shares Outstanding | 695.50M | 694.60M | 693.70M | 692.70M | 692.00M |
| Average Diluted Shares Outstanding | 699.90M | 698.40M | 696.70M | 694.60M | 692.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |